Cargando…

NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway

OBJECTIVE: Currently, cumulative evidence has shown that loss of NEK2 function suppresses tumor growth. However, complete studies on the regulatory role of NEK2 in clear-cellrenal-cell carcinoma (ccRCC) are rarely reported. METHODS: The GEPIA database was used for information mining to analyze the g...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Jiancheng, Lai, Jiawei, Cheng, Yongyi, Qu, Weixing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9536896/ https://www.ncbi.nlm.nih.gov/pubmed/36212952 http://dx.doi.org/10.1155/2022/1890823

Ejemplares similares

Retracted: NEK2 Serves as a Novel Biomarker and Enhances the Tumorigenicity of Clear-CellRenal-Cell Carcinoma by Activating WNT/β-Catenin Pathway
por: and Alternative Medicine, Evidence-Based Complementary
Publicado: (2023)

Overexpression of NEK2 is correlated with poor prognosis in human clear cell renal cell carcinoma
por: Wang, Chenfeng, et al.
Publicado: (2021)

NEK2 serves as a prognostic biomarker for hepatocellular carcinoma
por: Li, Gang, et al.
Publicado: (2017)

NEK2 promotes esophageal squamous cell carcinoma cell proliferation, migration and invasion through the Wnt/β-catenin signaling pathway
por: Guo, Dong, et al.
Publicado: (2023)

Impact of an Altered Wnt1/β-Catenin Expression on Clinicopathology and Prognosis in Clear Cell Renal Cell Carcinoma
por: Kruck, Stephan, et al.
Publicado: (2013)

CENPA promotes clear cell renal cell carcinoma progression and metastasis via Wnt/β-catenin signaling pathway
por: Wang, Qi, et al.
Publicado: (2021)

FUT2 promotes the tumorigenicity and metastasis of colorectal cancer cells via the Wnt/β-catenin pathway
por: Liu, Peng, et al.
Publicado: (2023)

The CSRNP Gene Family Serves as a Prognostic Biomarker in Clear Cell Renal Cell Carcinoma
por: Zhang, Huaru, et al.
Publicado: (2021)

Glycolysis-Related Genes Serve as Potential Prognostic Biomarkers in Clear Cell Renal Cell Carcinoma
por: Zhang, Yan, et al.
Publicado: (2021)

IQGAP3 May Serve as a Promising Biomarker in Clear Cell Renal Cell Carcinoma
por: Meng, Quan, et al.
Publicado: (2021)

Homologous recombination deficiency serves as a prognostic biomarker in clear cell renal cell carcinoma
por: He, Liping, et al.
Publicado: (2023)

ARL4C Regulates the Progression of Clear Cell Renal Cell Carcinoma by Affecting the Wnt/β-Catenin Signaling Pathway
por: Zhang, Peizhi, et al.
Publicado: (2022)

Nek2B activates the wnt pathway and promotes triple-negative breast cancer chemothezrapy-resistance by stabilizing β-catenin
por: Shen, Honghong, et al.
Publicado: (2019)

Targeting NEK2 impairs oncogenesis and radioresistance via inhibiting the Wnt1/β-catenin signaling pathway in cervical cancer
por: Xu, Tie, et al.
Publicado: (2020)

Protein Expression of NEK2, JMJD4, and REST in Clear Cell Renal Cell Carcinoma (ccRCC): Clinical, Pathological, and Prognostic Findings
por: Elsayed, Walid S H, et al.
Publicado: (2023)

FSIP2 can serve as a predictive biomarker for Clear Cell Renal Cell Carcinoma prognosis
por: Zhang, Yixiao, et al.
Publicado: (2020)

Nucleolar protein NOP2 could serve as a potential prognostic predictor for clear cell renal cell carcinoma
por: Wang, Gang, et al.
Publicado: (2021)

HMGCS2 serves as a potential biomarker for inhibition of renal clear cell carcinoma growth
por: Mao, Huajie, et al.
Publicado: (2023)

MicroRNA-1229 overexpression promotes cell proliferation and tumorigenicity and activates Wnt/β-catenin signaling in breast cancer
por: Tan, Zhanyao, et al.
Publicado: (2016)

MiR-744 increases tumorigenicity of pancreatic cancer by activating Wnt/β-catenin pathway
por: Zhou, Wei, et al.
Publicado: (2015)

Pro-Tumorigenic Phosphorylation of p120 Catenin in Renal and Breast Cancer
por: Kourtidis, Antonis, et al.
Publicado: (2015)

TLN2 functions as a tumor suppressor in clear cell renal cell carcinoma via inactivation of the Wnt/β-catenin signaling pathway
por: Cai, Jingshuang, et al.
Publicado: (2022)

RUNX2 interacts with SCD1 and activates Wnt/β‐catenin signaling pathway to promote the progression of clear cell renal cell carcinoma
por: Song, Xiandong, et al.
Publicado: (2022)

ISG20 serves as a potential biomarker and drives tumor progression in clear cell renal cell carcinoma
por: Xu, Tianbo, et al.
Publicado: (2020)

Aberrant Wnt/β-catenin signaling and elevated expression of stem cell proteins are associated with osteosarcoma side population cells of high tumorigenicity
por: YI, XI-JUN, et al.
Publicado: (2015)

BACH1 promotes clear cell renal cell carcinoma progression by upregulating oxidative stress‐related tumorigenicity
por: Takemoto, Kenshiro, et al.
Publicado: (2022)

KDM3 epigenetically controls tumorigenic potentials of human colorectal cancer stem cells through Wnt/β-catenin signalling
por: Li, Jiong, et al.
Publicado: (2017)

SALL4 promotes the tumorigenicity of cervical cancer cells through activation of the Wnt/β‐catenin pathway via CTNNB1
por: Chen, Mei, et al.
Publicado: (2019)

Interleukin-24 inhibits the phenotype and tumorigenicity of cancer stem cell in osteosarcoma via downregulation Notch and Wnt/β-catenin signaling
por: Zhuo, Baobiao, et al.
Publicado: (2021)

Alterations of the WNT7A Gene in Clear Cell Renal Cell Carcinomas
por: Kondratov, Aleksandr G., et al.
Publicado: (2012)

NK4 Regulates Laryngeal Squamous Cell Carcinoma Cell Properties and Inhibits Tumorigenicity by Modulating the DKK1/Wnt/β-Catenin Axis
por: Zhang, Shoukai, et al.
Publicado: (2021)

Immunohistochemical Expression of Wnt-4 Protein in Clear Cell Renal Carcinoma
por: Pavlovic, Oliver, et al.
Publicado: (2021)

Up-regulation of SR-BI promotes progression and serves as a prognostic biomarker in clear cell renal cell carcinoma
por: Xu, Guang-hua, et al.
Publicado: (2018)

Long Noncoding RNA HOTTIP Serves as an Independent Predictive Biomarker for the Prognosis of Patients with Clear Cell Renal Cell Carcinoma
por: Liu, Zhanxin, et al.
Publicado: (2020)

Immune-related long non-coding RNAs can serve as prognostic biomarkers for clear cell renal cell carcinoma
por: Li, Cheng Shan, et al.
Publicado: (2021)

Nek2 phosphorylates and stabilizes β-catenin at mitotic centrosomes downstream of Plk1
por: Mbom, Bertrade C., et al.
Publicado: (2014)

Cuproptosis-Related Genes Are Associated with Cell Cycle and Serve as the Prognostic Signature for Clear Cell Renal Cell Carcinoma
por: Guo, Tuanjie, et al.
Publicado: (2022)

TLR3 Serves as a Prognostic Biomarker and Associates with Immune Infiltration in the Renal Clear Cell Carcinoma Microenvironment
por: Liao, Guodong, et al.
Publicado: (2021)

Immune-Associated Gene Signatures Serve as a Promising Biomarker of Immunotherapeutic Prognosis for Renal Clear Cell Carcinoma
por: Wang, Qi, et al.
Publicado: (2022)

Low Expression of TSTD2 Serves as a Biomarker for Poor Prognosis in Kidney Renal Clear Cell Carcinoma
por: Tang, Gonglin, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_59bs1ko4cv56eijc959thh9d7l